BACKGROUND: Diabetes mellitus (DM) management primarily focuses on improvement in blood glucose concentrations and clinical signs. A tool to assess the psychological and social impact of DM and its treatment on quality of life (QoL) previously has only been validated for feline DM. HYPOTHESIS/ OBJECTIVES: To validate a diabetic pet and owner-centered individualized measure of impact of DM (DIAQoL-pet) for diabetic dogs and their owners. ANIMALS/ SUBJECTS: A total of 101 owners of insulin-treated diabetic dogs were recruited to complete the DIAQoL-pet. METHODS: Discussions and pilot surveys with clinicians and owners of diabetic pets led to the design of 29 specific DM-associated QoL questions. Each item was scored according to impact frequency and perceived importance. An Item-Weighted-Impact-Score (IWIS) for each item was calculated, as was an Average-Weighted-Impact-Score (AWIS) by averaging all IWISs. Principal component analysis and Cronbach's α calculation assessed the measure's reliability. RESULTS: The DIAQoL-pet showed high reliability (Communalities ≥0.5; Cronbach's α 0.85). The AWIS was -2.74 ± 1.7 (mean ± SD). Areas reported as most negatively impacting QoL included: "worry" (IWIS ± SD: -5.92 ± 4.3), "difficulties leaving dog with friends or family" (-5.68 ± 5.1), "worry vision" (-5.58 ± 4.6), "boarding difficulties" (-5.18 ± 5.2), "worry hypoglycemia" (-4.95 ± 4.3), "social life" (-4.82 ± 4.4), "costs" (-4.11 ± 4.7), and "future care"(-4.07 ± 4.6). Eighty-four percent of owners reported negative impact of DM on QoL. CONCLUSIONS AND CLINICAL IMPORTANCE: The DIAQoL-pet proved robust when used by owners of insulin-treated diabetic dogs and identified specific areas most negatively impacting dogs' and their owners' QoL. This tool could be used as an additional assessment parameter in clinical and research settings.
BACKGROUND:Diabetes mellitus (DM) management primarily focuses on improvement in blood glucose concentrations and clinical signs. A tool to assess the psychological and social impact of DM and its treatment on quality of life (QoL) previously has only been validated for feline DM. HYPOTHESIS/ OBJECTIVES: To validate a diabetic pet and owner-centered individualized measure of impact of DM (DIAQoL-pet) for diabeticdogs and their owners. ANIMALS/ SUBJECTS: A total of 101 owners of insulin-treated diabeticdogs were recruited to complete the DIAQoL-pet. METHODS: Discussions and pilot surveys with clinicians and owners of diabetic pets led to the design of 29 specific DM-associated QoL questions. Each item was scored according to impact frequency and perceived importance. An Item-Weighted-Impact-Score (IWIS) for each item was calculated, as was an Average-Weighted-Impact-Score (AWIS) by averaging all IWISs. Principal component analysis and Cronbach's α calculation assessed the measure's reliability. RESULTS: The DIAQoL-pet showed high reliability (Communalities ≥0.5; Cronbach's α 0.85). The AWIS was -2.74 ± 1.7 (mean ± SD). Areas reported as most negatively impacting QoL included: "worry" (IWIS ± SD: -5.92 ± 4.3), "difficulties leaving dog with friends or family" (-5.68 ± 5.1), "worry vision" (-5.58 ± 4.6), "boarding difficulties" (-5.18 ± 5.2), "worry hypoglycemia" (-4.95 ± 4.3), "social life" (-4.82 ± 4.4), "costs" (-4.11 ± 4.7), and "future care"(-4.07 ± 4.6). Eighty-four percent of owners reported negative impact of DM on QoL. CONCLUSIONS AND CLINICAL IMPORTANCE: The DIAQoL-pet proved robust when used by owners of insulin-treated diabeticdogs and identified specific areas most negatively impacting dogs' and their owners' QoL. This tool could be used as an additional assessment parameter in clinical and research settings.
Authors: Stijn J M Niessen; Katarina Hazuchova; Sonya L Powney; Javier Guitian; Antonius P M Niessen; Paul D Pion; James A Shaw; David B Church Journal: Vet Sci Date: 2017-05-14
Authors: Célia M C Strunz; Mário Marcondes-Santos; Julio Yoshio Takada; Fernanda S Fragata; Antônio de Pádua Mansur Journal: Arq Bras Cardiol Date: 2017-03-30 Impact factor: 2.000
Authors: Imogen Schofield; Dan G O'Neill; Dave C Brodbelt; David B Church; Rebecca F Geddes; Stijn J M Niessen Journal: J Vet Intern Med Date: 2019-10-29 Impact factor: 3.333